Clinical Trials Directory

Trials / Completed

CompletedNCT06152458

Blessing or Curse? Combined Vitamin Therapy in Non Viral Septic Shock.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
43 (actual)
Sponsor
University of Pecs · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Introduction: Septic shock leads to high morbidity and mortality in critically ill patients. Several lower-case scientific studies have supported the synergistic positive effect of vitamin C, thiamine, and hydrocortisone on sepsis-induced organ dysfunction. Aim: Our aim was to investigate the effect of vitamin complex on organ failure, laboratory parameters, respiratory and antibiotic treatment, intensive care time, and mortality in septic shock patients. Material and methods: In our retrospective and prospective analysis, we collected parameters from 43 (23 vitamin-treated, 20 control) septic shock patients. Patients treated with vitamin, they received vitamin C (4x1500 mg), thiamine (2x200 mg) for three days (2). In other respects, and for hydrocortisone (200 mg / 24h), both groups of patients received treatment according to the European Sepsis Recommendation. SPSS (V-21) data were used for data collection, Kolmogorov-Smirnov, Wilcoxon, Mann-Whitney U tests were used for statistical analysis. Ethical license: 7849-PTE 2019.

Conditions

Interventions

TypeNameDescription
DRUGVitamin CPatients in the intervention group (G1) (n=23) received the combined vitamin therapy: IV vitamin C (1.5 g every 6 hours administered as an infusion over 30 to 60 minutes and mixed in a 100- mL solution of normal saline), hydrocortisone (100 mg in bolus-100 mg in perfusor up to 60 min (200mg 24h),), and thiamine (200 mg every 12 hours administered as an infusion over 30 to 60 minutes and mixed in a 100-mL solution of normal saline) for 3 days.

Timeline

Start date
2019-01-01
Primary completion
2020-03-01
Completion
2020-03-01
First posted
2023-11-30
Last updated
2023-11-30

Locations

1 site across 1 country: Hungary

Source: ClinicalTrials.gov record NCT06152458. Inclusion in this directory is not an endorsement.